Congratulations to our Clinician-Scientist Professor Andrew Scott AM, who received two awards at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) meeting in the US last week.
The Minoshima-Pappas award recognises scientists who have demonstrated transformative leadership and reflects Professor Scott’s expertise in the field of nuclear medicine and molecular imaging.
“I am honoured to receive the Minoshima-Pappas award for transformative leadership this year, as it is an acknowledgement of many years of advocacy and strategic planning I have been involved in to improve the outcomes of patients through improved access to medical care.
“This has particularly involved collaborations and support from many senior leaders in the field, and both national and international organisations, such as ANZSNM, SNMMI, EANM, IAEA, WFNMB and WHO.”
Professor Scott also received the Henry Wagner Jr lecture award, which is presented to the speaker giving the main presentation in the opening plenary session. Each year, a leader in the field of nuclear medicine is invited by the SNMMI to give this important lecture.
During his opening plenary session presentation, Professor Scott spoke about molecular imaging and therapy, and highlighted the efforts required to improve global access and availability.
This follows Professor Scott’s recent achievement at the World Health Assembly, where he presented a resolution to improve global access to medical imaging, which was adopted by the World Health Organisation.
“For patients in low and middle-income countries (LMICs), access to imaging is quite limited and has a detrimental impact on early diagnosis of disease, and also impacts on decisions for appropriate management of chronic diseases. This results in poorer health outcomes for patients, and increases the number of deaths from curable diseases.”
Professor Scott reflects on the highlights from the conference:
“There were many highlights of the SNMMI meeting, including major talks on the impact of molecular imaging and theranostics on patient care, and new directions in imaging patients with cancer, dementia and heart disease.
“Australia and New Zealand were the highlight countries at this year’s SNMMI meeting, which is a fitting recognition of the contributions our countries have played in the global development of molecular imaging and theranostics.”
Join us in congratulating Professor Scott on these much-deserved achievements!